Susan Dexter

Susan Dexter is currently Independent Non-Executive Director at Sartorius Stedim Biotech SA since 2015, Director at Virocell, Inc., Director at Virica Biotech, Inc., and Chief Technical Officer at Sonnet BioTherapeutics, Inc. since 2020.
Former positions include Managing Director at Latham BioPharm Group, Inc. from 2008 to 2020, Vice President-Business Development at The Dow Chemical Co. from 1998 to 2004, Chief Business Officer at Xcellerex, Inc. from 2004 to 2008, Associate Director-Business Development at Lonza Biologics Plc from 1986 to 1998, Director & Chief Marketing Officer at FUJIFILM Diosynth Biotechnologies Texas LLC, Director at BioSense Technologies, Director at City of College Station (Texas), Vice President-Business & Strategic Development at Collaborative BioAlliance Inc & Collaborative Smithfield Corp, Professor-Emeritus at University College London, Director at BioSense Technologies, and Chief Technical Officer at Sonnet BioTherapeutics Holdings, Inc. from 2020 to 2025.
Education includes undergraduate degrees from Harvard University and American University.